InvestSMART

Sonic Healthcare Limited (ASX: SHL) - Announcements

Current share price for SHL : $19.000 0.37 (1.91%)+

ASX company news and announcements for Sonic Healthcare Limited (SHL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Sonic Healthcare Limited (SHL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Sonic Healthcare Limited (SHL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Sonic Healthcare Limited (SHL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9,391 Change of Director's Interest Notice 4 Mar 2022 4:16PM $33.240 $19.000 fallen by 42.84%
$9,391 Notification of cessation of securities - SHL 3 Mar 2022 4:20PM $33.500 $19.000 fallen by 43.28%
$9,391 Notification regarding unquoted securities - SHL 1 Mar 2022 4:26PM $34.690 $19.000 fallen by 45.23%
$9,391 Notification of buy-back - SHL 21 Feb 2022 9:12AM $37.600 $19.000 fallen by 49.47%
$9,391 On-Market Share Buy-Back 21 Feb 2022 9:08AM $37.600 $19.000 fallen by 49.47%
$9,391 CEO Presentation Half Year Results to 31 December 2021 21 Feb 2022 8:57AM $37.600 $19.000 fallen by 49.47%
$9,391 Media Release Half Year Results to 31 December 2021 21 Feb 2022 8:54AM $37.600 $19.000 fallen by 49.47%
$9,391 Dividend/Distribution - SHL 21 Feb 2022 8:48AM $37.600 $19.000 fallen by 49.47%
$9,391 Half Yearly Report and Accounts 21 Feb 2022 8:46AM $37.600 $19.000 fallen by 49.47%
$9,391 Application for quotation of securities - SHL 1 Feb 2022 4:59PM $38.290 $19.000 fallen by 50.38%
$9,391 Sonic Healthcare acquires ProPath 17 Dec 2021 8:21AM $44.230 $19.000 fallen by 57.04%
$9,391 Application for quotation of securities - SHL 16 Dec 2021 4:27PM $44.230 $19.000 fallen by 57.04%
$9,391 Sonic Healthcare & Harrison.ai Partner in Pathology A.I. JV 30 Nov 2021 8:15PM $42.700 $19.000 fallen by 55.50%
$9,391 Change of Director's Interest Notice 25 Nov 2021 4:21PM $41.520 $19.000 fallen by 54.24%
$9,391 Change of Director's Interest Notice 25 Nov 2021 4:20PM $41.520 $19.000 fallen by 54.24%
$9,391 Notification regarding unquoted securities - SHL 24 Nov 2021 5:04PM $41.460 $19.000 fallen by 54.17%
$9,391 Ceasing to be a substantial holder 19 Nov 2021 8:19AM $39.750 $19.000 fallen by 52.20%
$9,391 Notification regarding unquoted securities - SHL 18 Nov 2021 7:10PM $39.750 $19.000 fallen by 52.20%
$9,391 Notification regarding unquoted securities - SHL 18 Nov 2021 6:53PM $39.750 $19.000 fallen by 52.20%
$9,391 Results of Meeting 18 Nov 2021 2:01PM $39.860 $19.000 fallen by 52.33%
$9,391 Sonic 2021 AGM - CEO Presentation 18 Nov 2021 9:32AM $38.580 $19.000 fallen by 50.75%
$9,391 Chairman's Address to Shareholders 18 Nov 2021 9:23AM $38.580 $19.000 fallen by 50.75%
$9,391 Trading Update - Results 4 months to October 2021 18 Nov 2021 9:05AM $38.580 $19.000 fallen by 50.75%
$9,391 Application for quotation of securities - SHL 11 Nov 2021 4:36PM $38.710 $19.000 fallen by 50.92%
$9,391 Ceasing to be a substantial holder 11 Nov 2021 8:32AM $39.370 $19.000 fallen by 51.74%

351 - 375 of 845 results

Page 15 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.